Search results
... Is Arcus Biosciences Stock Trading Higher Today? - Arcus Biosciences (NYSE:RCUS), Gilead ...
Benzinga· 2 days agoGilead Sciences and Arcus Biosciences report sustained efficacy and safety in the Phase 2 EDGE-Gastric study for upper GI cancers, showing improved progression-free ...
Top Stock Reports for NextEra Energy, BP & Gilead Sciences
Zacks via Yahoo Finance· 2 days agoToday's Research Daily features new research reports on 16 major stocks, including NextEra Energy,...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters via Yahoo News· 6 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...
Hedge Funds are Bullish on This Gene Therapy Stock
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss Gilead Sciences, Inc. (NASDAQ:GILD), which is...
Gilead, with approval in sight, shows $4.3B liver disease drug improves outcomes out to 2 years
FierceBiotech· 6 hours agoThe molecule, seladelpar, had already moved the needle in a phase 3 trial by the time Gilead paid...
Lilly details MASH data for tirzepatide; Cytokinetics comments on past sale talks
BioPharma Dive via Yahoo Finance· 5 hours agoA study abstract shed more light on tirzepatide’s potential in MASH. Elsewhere, Cytokinetics CEO...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters via Yahoo News· 5 days ago(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder...
Gilead’s Phase III urothelial cancer trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 5 days agoGilead Sciences has reported that its Phase III TROPiCS-04 clinical trial of Trodelvy in patients...
Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
Zacks via Yahoo Finance· 5 days agoGilead Sciences, Inc.'s (GILD) confirmatory TROPiCS-04 study on Trodelvy in locally advanced or...
National Institutes of Health Kickstarts Gilead Sponsored Trials For Twice-Yearly HIV Prevention...
Benzinga· 19 hours agoThe mid-stage studies will assess the safety, acceptability, and pharmacokinetics (how a drug moves...